XHR(XHR)
XHR
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.12B | $1.16B | $1.18B |
| Low | $1.12B | $1.14B | $1.18B |
| High | $1.13B | $1.18B | $1.18B |
| EBITDA Avg | $416M | $427M | $437M |
| Low | $414M | $422M | $436M |
| High | $419M | $436M | $438M |
| EBIT Avg | $354M | $364M | $373M |
| Low | $352M | $360M | $372M |
| High | $357M | $372M | $373M |
| Net Income Avg | $18M | $55M | — |
| Low | $17M | $53M | — |
| High | $19M | $70M | — |
| EPS Avg | $0.18 | $0.64 | — |
| Low | $0.18 | $0.55 | — |
| High | $0.19 | $0.72 | — |
| Analysts (Rev / EPS) | 1 / 1 | 5 / 2 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $251M | $275M | $301M | $313M | $259M | $283M |
| Low | $251M | $275M | $301M | $313M | $259M | $283M |
| High | $251M | $275M | $301M | $313M | $259M | $283M |
| EBITDA Avg | $93M | $102M | $111M | $116M | $96M | $105M |
| Low | $93M | $102M | $111M | $116M | $96M | $105M |
| High | $93M | $102M | $111M | $116M | $96M | $105M |
| EBIT Avg | $79M | $87M | $95M | $99M | $82M | $89M |
| Low | $79M | $87M | $95M | $99M | $82M | $89M |
| High | $79M | $87M | $95M | $99M | $82M | $89M |
| Net Income Avg | $-12M | $4M | $29M | $26M | $-7M | $11M |
| Low | $-12M | $4M | $29M | $26M | $-7M | $11M |
| High | $-12M | $4M | $29M | $26M | $-7M | $11M |
| EPS Avg | $-0.13 | $0.04 | $0.31 | $0.28 | $-0.08 | $0.12 |
| Low | $-0.13 | $0.04 | $0.31 | $0.28 | $-0.08 | $0.12 |
| High | $-0.13 | $0.05 | $0.31 | $0.28 | $-0.08 | $0.12 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |